Abstract
Ocular ischemic syndrome (OIS) is defined as the ocular manifestations of severe carotid artery stenosis or occlusion. For some patients, the first indication of carotid disease is OIS. Diagnosing a patient with OIS gives them a poor prognosis for both ocular and systemic morbidity, but may provide the physician with an opportunity to prevent a major stroke (Sivalingam et al. 1989, 1991). Since OIS was first described in 1963 (Hedges 1963; Kearns and Hollenhort 1963), imaging techniques have evolved, improving our ability to characterize the ocular findings of this disease. Although other authors have used the term venous stasis retinopathy, we will use the term ocular ischemic syndrome in this chapter (Brown et al. 2018).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Amselem L, Montero J, Diaz-llopis M, et al. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome. Am J Ophthalmol. 2007;144:122–4.
Arend WP, Michel BA, Block DA, et al. The american college of rheumatology 1990 criteria for the classification of takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.
Barnett HJM, North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–53.
Bogousslavsky J, Pedrazzi PL, Borruat FX, Regli F. Isolated complete orbital infarction: a common carotid artery occlusion syndrome. Eur Neurol. 1991;31:72–6.
Brown GC, Magargal LE. The ocular ischemic syndrome: clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11:239–51.
Brown GC, Sharma S, Brown MM. Ocular ischemic syndrome. In: Schachat AP, Sadda SR, Hinton DR, Wilkinson CP, Wiedemann P, editors. Ryan’s retina. 6th ed. London: Elsevier; 2018. p. 1227–39.
Bullock JD, Falter RT, Downing JE, Snyder HE. Ischemic ophthalmia secondary to an ophthalmic artery occlusion. Am J Ophthalmol. 1972;74:486–93.
Chun YS, Park SJ, Park IK, et al. The clinical and ocular manifestations of Takayasu arteritis. Retina. 2001;21:132–40.
Duker JS, Belmont JB. Ocular ischemic syndrome secondary to carotid artery dissection. Am J Ophthalmol. 1988;106:750–2.
Gewaily DY, Grunwald JE, Pistilli M, et al. Delayed patchy choroidal filling in the comparison of age-related macular degeneration treatments trials (CATT). Am J Ophthalmol. 2014;158:525–31.
Hamed LM, Guy JR, Moster ML, Bosley T. Giant cell arteritis in the ocular ischemic syndrome. Am J Ophthalmol. 1992;113:702–5.
Hayreh SS, Zimmerman MB. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses. Retina. 2014;34:115–22.
Hedges TR. Ophthalmoscopic findings in internal carotid artery occlusion. Am J Ophthalmol. 1963;55:1007–12.
Hu HH, Sheng WY, Yen MY, et al. Color Doppler imaging of orbital arteries for detection of carotid occlusive disease. Stroke. 1993;24:1196–203.
Hwang J-M, Girkin CA, Perry JD, et al. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. Am J Ophthalmol. 1999;127:102–4.
Kang HM, Lee CS, Lee SC. Thinner subfoveal choroidal thickness in eyes with ocular ischemic syndrome than in unaffected contralateral eyes. Graefes Arch Clin Exp Ophthalmol. 2014;252:851–2.
Kawaguchi S, Okuno S, Sakaki T, Nishikawa N. Effect of carotid endarterectomy on chronic ocular ischemic syndrome due to internal carotid artery stenosis. Neurosurgery. 2001;48:328–33.
Kearns TP, Hollenhort RW. Venous-stasis retinopathy of occlusive disease of the carotid artery. Staff Meet Mayo Clin. 1963;38:304–12.
Klijn CJM, Kappelle LJ, van Schooneveld MJ, et al. Venous stasis retinopathy in symptomatic carotid artery occlusion: prevalence, cause, and outcome. Stroke. 2002;33:695–701.
Lupidi M, Fiore T, Cerquaglia A, et al. Depth-resolved imaging of papillary vitreoretinal neovascularization: OCT-angiography assessment in ocular ischemic syndrome. Retina. 2017;37:e42–4.
Mack HG, O’Day J, Currie JN. Delayed choroidal perfusion in giant cell arteritis. J Clin Neuroophthalmol. 1991;11:221–7.
Malhotra R, Gregory-Evans K. Management of ocular ischaemic syndrome. Br J Ophthalmol. 2000;84:1428–31.
Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55:2–34.
Mizener B, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104:859–64.
Sivalingam A, Brown GC, Magargal LE, Menduke H. The ocular ischemic syndrome II. Mortality and systemic morbidity. Int Ophthalmol. 1989;13:187–91.
Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome III. Visual prognosis and the effect of treatment. Int Ophthalmol. 1991;15:15–20.
Streifler JY, Eliasziw M, Benavente OR, et al. The risk of stroke in patients with first-ever retinal vs. hemispheric transient ischemic attacks and high-grade carotid stenosis. Arch Neurol. 1995;52:246–9.
Utsugi N, Takahashi K, Kishi S. Choroidal vascular occlusion in internal carotid artery obstruction. Retina. 2004;24:915–9.
Wardlaw J, Chappell F, Best J, et al. Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet. 2006;367:1503–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kim, J.E., Hwang, E.S. (2020). Ocular Ischemic Syndrome. In: Sheyman, A., Fawzi, A.A. (eds) Retinal Vascular Disease. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-15-4075-2_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-4075-2_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4074-5
Online ISBN: 978-981-15-4075-2
eBook Packages: MedicineMedicine (R0)